Clinical Trial Update: Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation trial of re-irradiation in good-prognosis recurrent glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma Grade Iv
• Giant Cell Glioblastoma
• Glioblastoma
• Gliosarcoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Astrocytoma, Grade IV, Giant Cell Glioblastoma | Phase 1 | Status: COMPLETED